| Chris
Kroeger, M.D. Partner - Aurora Funds |
As the partner at Aurora Funds, Dr. Kroeger primarily focuses
on investments in drug discovery, biotech and medical devices.
He previously trained in general surgery at Brigham and Women's
Hospital/Harvard Medical School where he was involved in the care
of transplant, trauma, vascular cardiac and general surgical patients.
He also has significant basic science research experience, including
work on the molecular biology and genetics of apoptosis, and the
transcriptional regulation of Interleukin-2 in human T-cells.
Dr. Kroeger received a B.A. in Biology from Harvard University,
his M.D. from Stanford University School of Medicine and an MBA
from Harvard Business School. While in business school, he worked
in Corporate Development at Genzyme and co-led an independent
project formulating licensing strategies in Biogen's business
development unit. Dr. Kroeger also worked at Arthur D. Little,
performing industry analysis for the biotechnology and pharmaceutical
industries.
|
|
|
